Mitsubishi UFJ Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1K | Sell |
50
-15,032
| -100% | -$3.63M | ﹤0.01% | 1300 |
|
|
2025
Q1 | $3.67M | Hold |
15,082
| – | – | ﹤0.01% | 674 |
|
|
2024
Q4 | $4.99M | Hold |
15,082
| – | – | ﹤0.01% | 655 |
|
|
2024
Q3 | $5.05M | Sell |
15,082
-12,142
| -45% | -$4.06M | 0.01% | 653 |
|
|
2024
Q2 | $7.44M | Buy |
27,224
+4,374
| +19% | +$1.19M | 0.01% | 587 |
|
|
2024
Q1 | $7.9M | Buy |
22,850
+2,113
| +10% | +$731K | 0.01% | 568 |
|
|
2023
Q4 | $6.61M | Buy |
20,737
+38
| +0.2% | +$12.1K | 0.01% | 558 |
|
|
2023
Q3 | $7.42M | Buy |
20,699
+1,497
| +8% | +$537K | 0.02% | 534 |
|
|
2023
Q2 | $7.28M | Buy |
19,202
+3,207
| +20% | +$1.22M | 0.02% | 533 |
|
|
2023
Q1 | $7.66M | Buy |
15,995
+52
| +0.3% | +$24.9K | 0.02% | 519 |
|
|
2022
Q4 | $6.73M | Buy |
15,943
+2,569
| +19% | +$1.09M | 0.02% | 519 |
|
|
2022
Q3 | $5.58M | Buy |
13,374
+701
| +6% | +$292K | 0.02% | 524 |
|
|
2022
Q2 | $6.27M | Buy |
12,673
+981
| +8% | +$486K | 0.03% | 509 |
|
|
2022
Q1 | $6.59M | Buy |
11,692
+1,605
| +16% | +$904K | 0.03% | 522 |
|
|
2021
Q4 | $7.42M | Buy |
10,087
+724
| +8% | +$532K | 0.03% | 509 |
|
|
2021
Q3 | $6.98M | Buy |
9,363
+1,255
| +15% | +$936K | 0.03% | 487 |
|
|
2021
Q2 | $5.22M | Buy |
8,108
+668
| +9% | +$430K | 0.03% | 545 |
|
|
2021
Q1 | $4.25M | Buy |
7,440
+898
| +14% | +$513K | 0.03% | 542 |
|
|
2020
Q4 | $3.81M | Buy |
6,542
+761
| +13% | +$444K | 0.03% | 514 |
|
|
2020
Q3 | $2.98M | Buy |
5,781
+748
| +15% | +$386K | 0.03% | 497 |
|
|
2020
Q2 | $2.27M | Buy |
5,033
+1,752
| +53% | +$791K | 0.03% | 507 |
|
|
2020
Q1 | $1.15M | Sell |
3,281
-123
| -4% | -$43.1K | 0.02% | 593 |
|
|
2019
Q4 | $1.25M | Buy |
+3,404
| New | +$1.25M | 0.02% | 651 |
|